Research & Development



  至于勛貴,他覺得沒必要憐憫,一個自願在攫取權力,財富道路上奮勇直前的人,也不需要別人憐憫。   歌舞喧鬧到了半夜這才停止,隋越打開門對周圍的將士們道︰“陛下已經安寢,諸君不得嘈雜!”彩票生日选号器   王溫舒迷茫的厲害,他不明白雲瑯的行為以及這些晦澀難懂地話到底要達成一個怎樣的目的。中国福利彩票双色球基本走势图   “這是什麼話?”   一個年級很老的胥吏,探手就捉住了刀刃,單手捏著刀刃就從農桑手里奪過了長刀,順勢一腳踹翻了農桑,召喚過來一匹馬,將昏過去的農桑放在馬背上。彩票双色球下期预测号码   守在門外的李陵非常的有眼色,沒有大聲的傳達隋越的話,而是悄悄地將這句話傳給了身邊的人。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo